Literature DB >> 12045396

Recent studies on interactions between n-3 and n-6 polyunsaturated fatty acids in brain and other tissues.

Miguel A Contreras1, Stanley I Rapoport.   

Abstract

Recent literature provides a basis for understanding the behavioral, functional, and structural consequences of nutritional deprivation or disease-related abnormalities of n-3 polyunsaturated fatty acids. The literature suggests that these effects are mediated through competition between n-3 and n-6 polyunsaturated fatty acids at certain enzymatic steps, particularly those involving polyunsaturated fatty acid elongation and desaturation. One critical enzymatic site is a delta6-desaturase. On the other hand, an in-vivo method in rats, applied following chronic n-3 nutritional deprivation or chronic administration of lithium, indicates that the cycles of de-esterification/re-esterification of docosahexaenoic acid (22:6n-3) and arachidonic acid (20:4n-6) within brain phospholipids operate independently of each other, and thus that the enzymes regulating each of these cycles are not likely sites of n-3/n-6 competition.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12045396     DOI: 10.1097/00041433-200206000-00006

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  26 in total

1.  Dietary n-6 PUFA deprivation downregulates arachidonate but upregulates docosahexaenoate metabolizing enzymes in rat brain.

Authors:  Hyung-Wook Kim; Jagadeesh S Rao; Stanley I Rapoport; Miki Igarashi
Journal:  Biochim Biophys Acta       Date:  2010-11-09

Review 2.  Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease.

Authors:  Je-Seong Won; Avtar K Singh; Inderjit Singh
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

3.  Regulation of rat brain polyunsaturated fatty acid (PUFA) metabolism during graded dietary n-3 PUFA deprivation.

Authors:  Hyung-Wook Kim; Jagadeesh S Rao; Stanley I Rapoport; Miki Igarashi
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2011-08-30       Impact factor: 4.006

4.  Role of endogenous psychosine accumulation in oligodendrocyte differentiation and survival: implication for Krabbe disease.

Authors:  Je-Seong Won; Jinsu Kim; Manjeet Kaur Paintlia; Inderjit Singh; Avtar K Singh
Journal:  Brain Res       Date:  2013-02-21       Impact factor: 3.252

5.  Extracellular-derived calcium does not initiate in vivo neurotransmission involving docosahexaenoic acid.

Authors:  Epolia Ramadan; Angelo O Rosa; Lisa Chang; Mei Chen; Stanley I Rapoport; Mireille Basselin
Journal:  J Lipid Res       Date:  2010-04-13       Impact factor: 5.922

6.  Disturbed brain phospholipid and docosahexaenoic acid metabolism in calcium-independent phospholipase A(2)-VIA (iPLA(2)β)-knockout mice.

Authors:  Yewon Cheon; Hyung-Wook Kim; Miki Igarashi; Hiren R Modi; Lisa Chang; Kaizong Ma; Deanna Greenstein; Mary Wohltmann; John Turk; Stanley I Rapoport; Ameer Y Taha
Journal:  Biochim Biophys Acta       Date:  2012-02-10

7.  Whole-body synthesis-secretion rates of long-chain n-3 PUFAs from circulating unesterified alpha-linolenic acid in unanesthetized rats.

Authors:  Fei Gao; Dale Kiesewetter; Lisa Chang; Kaizong Ma; Jane M Bell; Stanley I Rapoport; Miki Igarashi
Journal:  J Lipid Res       Date:  2008-12-11       Impact factor: 5.922

8.  Dietary n-6 PUFA deprivation for 15 weeks reduces arachidonic acid concentrations while increasing n-3 PUFA concentrations in organs of post-weaning male rats.

Authors:  Miki Igarashi; Fei Gao; Hyung-Wook Kim; Kaizong Ma; Jane M Bell; Stanley I Rapoport
Journal:  Biochim Biophys Acta       Date:  2008-11-27

9.  Chronic risperidone treatment preferentially increases rat erythrocyte and prefrontal cortex omega-3 fatty acid composition: evidence for augmented biosynthesis.

Authors:  Robert K McNamara; Jessica A Able; Ronald Jandacek; Therese Rider; Patrick Tso
Journal:  Schizophr Res       Date:  2008-11-07       Impact factor: 4.939

10.  Membrane omega-3 Fatty Acid deficiency as a preventable risk factor for comorbid coronary heart disease in major depressive disorder.

Authors:  Robert K McNamara
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.